Company · CIK 1710340
Eton Pharmaceuticals, Inc.
| CIK | 1710340 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | IL |
| Listed | ETON (Nasdaq) |
| First annual or quarterly report | 2018-12-20 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-271196 | 2023-04-07 | 2024-12-12 | 3 | |
| 333-235329 | 2019-12-02 | 2020-10-15 | 5 | |
| 333-240252 | 2020-07-31 | 2020-08-25 | 2 | |
| 333-226774 | 2018-08-10 | 2018-11-13 | 7 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-12-12 | 424B5Shelf takedown | 333-271196 | 0001437749-24-037363 |
| 2023-05-02 | EFFECTDeclared effective | 333-271196 | 9999999995-23-001235 |
| 2023-04-07 | S-3Shelf registered | 333-271196 | 0001493152-23-011600 |
| 2020-10-15 | 424B5Shelf takedown | 333-235329 | 0001493152-20-019503 |
| 2020-10-13 | 424B5Shelf takedown | 333-235329 | 0001493152-20-019347 |
| 2020-08-25 | EFFECTDeclared effective | 333-240252 | 9999999995-20-002245 |
| 2020-07-31 | S-3Shelf registered | 333-240252 | 0001493152-20-014330 |
| 2020-03-30 | 424B5Shelf takedown | 333-235329 | 0001493152-20-005038 |
| 2019-12-16 | EFFECTDeclared effective | 333-235329 | 9999999995-19-002824 |
| 2019-12-02 | S-3Shelf registered | 333-235329 | 0001493152-19-018638 |
| 2018-11-13 | 424B4Final prospectus | 333-226774 | 0001615774-18-012575 |
| 2018-11-09 | EFFECTDeclared effective | 333-226774 | 9999999995-18-002850 |
| 2018-11-05 | S-1/AAmendment | 333-226774 | 0001615774-18-012090 |
| 2018-10-31 | S-1/AAmendment | 333-226774 | 0001615774-18-011677 |
| 2018-10-18 | S-1/AAmendment | 333-226774 | 0001615774-18-011027 |
| 2018-09-25 | S-1/AAmendment | 333-226774 | 0001615774-18-009956 |
| 2018-08-10 | S-1Registration filed | 333-226774 | 0001615774-18-007833 |
| 2018-03-20 | DRSDraft made public | 377-01980 | 0001615774-18-002013 |